XML 63 R54.htm IDEA: XBRL DOCUMENT v3.22.2
Subsequent Event (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Aug. 02, 2022
Feb. 05, 2021
Feb. 04, 2020
Jun. 30, 2022
Jun. 30, 2021
Jul. 29, 2022
Subsequent Event [Line Items]            
Proceeds from issuance of common stock, net of issuance costs       $ 0 $ 207,490  
Common Stock | Underwriters' option            
Subsequent Event [Line Items]            
Number of shares issued in transaction (in shares)   825,000 1,406,250      
Subsequent Event | AstraZeneca            
Subsequent Event [Line Items]            
Maximum product milestone payments upon first product approval           $ 7,500
Subsequent Event | Tranche B term loan | Loan agreement | Secured debt            
Subsequent Event [Line Items]            
Proceeds from issuance of debt $ 125,000          
Subsequent Event | Fourth Equity Public Offering            
Subsequent Event [Line Items]            
Proceeds from issuance of common stock, net of issuance costs 161,700          
Subsequent Event | Underwriters' option            
Subsequent Event [Line Items]            
Proceeds from issuance of common stock, net of issuance costs $ 161,700          
Subsequent Event | Common Stock | Fourth Equity Public Offering            
Subsequent Event [Line Items]            
Number of shares issued in transaction (in shares) 8,625,000          
Stock price (in USD per share) $ 20.00          
Subsequent Event | Common Stock | Underwriters' option            
Subsequent Event [Line Items]            
Number of shares issued in transaction (in shares) 1,125,000